Follow
Santanu Hati
Santanu Hati
Postdoctoral Research Fellow, School of Medicine, Creighton University.
Verified email at creighton.edu
Title
Cited by
Cited by
Year
Spiro [pyrrolidine-3, 3-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification
S Hati, S Tripathy, PK Dutta, R Agarwal, R Srinivasan, A Singh, S Singh, ...
Scientific reports 6 (1), 32213, 2016
792016
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity
P Majumdar, C Bathula, SM Basu, SK Das, R Agarwal, S Hati, A Singh, ...
European journal of medicinal chemistry 102, 540-551, 2015
742015
Accessing benzimidazoles via a ring distortion strategy: an oxone mediated tandem reaction of 2-Aminobenzylamines
S Hati, P Kumar Dutta, S Dutta, P Munshi, S Sen
Organic letters 18 (13), 3090-3093, 2016
472016
Oxidative dehydrogenation of C–C and C–N bonds: A convenient approach to access diverse (dihydro) heteroaromatic compounds
S Hati, U Holzgrabe, S Sen
Beilstein Journal of Organic Chemistry 13 (1), 1670-1692, 2017
392017
Synthesis of quinazolines and dihydroquinazolines: o-iodoxybenzoic acid mediated tandem reaction of o-aminobenzylamine with aldehydes
S Hati, S Sen
Synthesis, 1389-1398, 2016
372016
Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors
S Hati, SM Madurkar, C Bathula, C Thulluri, R Agarwal, FA Siddiqui, ...
European Journal of Medicinal Chemistry 100, 188-196, 2015
332015
N-Bromo-succinimide promoted synthesis of β-carbolines and 3, 4-dihydro-β-carbolines from tetrahydro-β-carbolines
S Hati, S Sen
Tetrahedron Letters 57 (9), 1040-1043, 2016
312016
Diverse synthesis of natural product inspired fused and spiro-heterocyclic scaffolds via ring distortion and ring construction strategies
C Bathula, P Dangi, S Hati, R Agarwal, P Munshi, A Singh, S Singh, S Sen
New Journal of Chemistry 39 (12), 9281-9292, 2015
232015
AZD5438-PROTAC: a selective CDK2 degrader that protects against cisplatin-and noise-induced hearing loss
S Hati, M Zallocchi, R Hazlitt, Y Li, S Vijayakumar, J Min, Z Rankovic, ...
European journal of medicinal chemistry 226, 113849, 2021
212021
Cerium chloride catalyzed, 2‐iodoxybenzoic acid mediated oxidative dehydrogenation of multiple heterocycles at room temperature
S Hati, S Sen
European Journal of Organic Chemistry 2017 (9), 1277-1280, 2017
202017
Diversity-oriented asymmetric synthesis
S Sen, G Prabhu, C Bathula, S Hati
Synthesis 46 (16), 2099-2121, 2014
182014
Transcriptome analysis predicts mode of action of benzimidazole molecules against Staphylococcus aureus UAMS‐1
D Chauhan, S Hati, R Priyadarshini, S Sen
Drug Development Research 80 (4), 490-503, 2019
132019
A novel spiroindoline targets cell cycle and migration via modulation of microtubule cytoskeleton
N Kumar, S Hati, P Munshi, S Sen, S Sehrawat, S Singh
Molecular and cellular biochemistry 429, 11-21, 2017
122017
Exploring the structure–activity relationship and mechanism of a chromene scaffold (CXL series) for its selective antiproliferative activity toward multidrug-resistant cancer cells
T Bian, K Chandagirikoppal Vijendra, Y Wang, A Meacham, S Hati, ...
Journal of medicinal chemistry 61 (15), 6892-6903, 2018
112018
Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss
M Zallocchi, S Hati, Z Xu, W Hausman, H Liu, DZ He, J Zuo
JCI insight 6 (5), 2021
92021
Bioisosteric modification of known fucosidase inhibitors to discover a novel inhibitor of α-l-fucosidase
C Bathula, S Ghosh, S Hati, S Tripathy, S Singh, S Chakrabarti, S Sen
RSC advances 7 (6), 3563-3572, 2017
72017
In vivo Structure‐Activity Relationship of Dihydromethysticin in Reducing Nicotine‐Derived Nitrosamine Ketone (NNK)‐Induced Lung DNA Damage against Lung …
S Hati, Q Hu, Z Huo, J Lu, C Xing
ChemMedChem 17 (7), e202100727, 2022
22022
In silico transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing loss
P Salehi, M Zallocchi, S Vijayakumar, M Urbanek, KP Giffen, Y Li, S Hati, ...
bioRxiv, 2022.01. 26.477836, 2022
22022
Compositions, use, and method for CDK2-PROTACs for cancer therapy and hearing loss
J Zuo, S Hati, ML Zallocchi, R Hazlitt, J Min
US Patent 11,744,896, 2023
12023
Structure-activity relationship of dihydromethysticin on NNK-induced lung DNA damage in A/J mice
S Hati, Q Hu, P Corral, J Lu, C Xing
J Mice, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20